Weekly: Halozyme Therapeutics (HALO: $35.16) falls for a fourth consecutive week, a four-week fall of 11%; -$1.39 [3.8%]

Media coverage

• Title	Weekly: Halozyme Therapeutics (HALO: $35.16) falls for a fourth consecutive week, a four-week fall of 11%; -$1.39 [3.8%]
  Media name/outlet	Global Round Up - Bullish & Bearish Signals
  Country/Territory	United States
  Date	10/21/23
  Persons	Mary Daly